Journal article

BRAF, a Target in Melanoma Implications for Solid Tumor Drug Development

Keith T Flaherty, Grant McArthur

Cancer | JOHN WILEY & SONS INC | Published : 2010

DOI: 10.1002/cncr.25261

University of Melbourne Researchers

Citation metrics

83Web of Science
87Scopus

Keywords

Antineoplastic Agents
Proto-Oncogene Proteins B-Raf
Mismatch Repair Deficiency
Braf
Antitumor-Activity
Phase-I
Kinase Inhibitor
Gastrointestinal Stromal Tumors
Humans
Melanoma
Oncogene
Oncology
Enzyme Activation
Protein Kinase Inhibitors
B-Raf
Acquired-Resistance
Life Sciences & Biomedicine
Malignant Melanocytic Lesions
Drug Delivery Systems
Signaling Pathway
Papillary Thyroid-Carcinoma
Skin Neoplasms
Mutation
Antineoplastic Combined Chemotherapy Protocols
Azd6244 Arry-142886
Science & Technology
Map Kinase Signaling System
Drug Resistance, Neoplasm